Day One Biopharmaceuticals, Inc. Liquidation Value
DAWN
Other
Cash & Equivalents
$197.08M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $197.08M
Total Obligations: -$63.31M
$133.76M
Per share: $1.30
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $197.08M
AR: $26.73M
Total Obligations: -$63.31M
$160.50M
Per share: $1.56
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $197.08M
AR: $26.73M
Inventory: $6.33M
Total Obligations: -$63.31M
$166.82M
Per share: $1.62
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $133.76M | $1.30 |
| Liquid Liquidation Value | $160.50M | $1.56 |
| Operating Liquidation Value | $166.82M | $1.62 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $197.08M |
| Accounts Receivable | $26.73M |
| Inventory | $6.33M |
| Current Liabilities | $60.52M |
| Long-term Debt | N/A |
| Op. Lease Liability | $2.79M |
| Finance Lease | N/A |
| Shares Outstanding | 103.0M |
Explore all 169 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $197.08M | $26.73M | $6.33M | $3.73M | $60.52M | N/A | $2.79M | N/A |
| 2025-09-30 | $43.28M | $16.70M | $7.06M | $5.78M | $56.47M | N/A | $2.89M | N/A |
| 2025-06-30 | $35.62M | $19.67M | $6.54M | $5.09M | $51.22M | N/A | $3.00M | N/A |
| 2025-03-31 | $33.36M | $18.05M | $3.56M | $2.54M | $47.88M | N/A | $2.92M | N/A |
| 2024-12-31 | $124.97M | $13.88M | $3.32M | $3.26M | $73.45M | N/A | $2.60M | N/A |
| 2024-09-30 | $422.76M | $8.70M | $2.73M | $3.02M | $39.74M | N/A | $2.62M | N/A |
| 2024-06-30 | $239.62M | $9.14M | $151,000 | $6.44M | $93.71M | N/A | $190,000 | N/A |
| 2024-03-31 | $270.39M | N/A | N/A | $4.78M | $29.84M | N/A | $300,000 | N/A |
▼ Community Notes